May 1, 2024Open Access

Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success

HMHana MüllerováAstraZeneca (United Kingdom)JCJeffrey Shi Kai ChanHeart Foundation HHHeath HeatleyObservational & Pragmatic Research Institute

Key Points

Key points are not available for this paper at this time.

Abstract

Real-life research is needed to evaluate the effectiveness of budesonide/glycopyrrolate/formoterol (BGF) in routine COPD primary care management. We assessed the frequency of medication success among patients with COPD who initiated BGF using real-world data.

KI fragen

Bookmark

View Full Paper

Cite This Study

Müllerová et al. (Wed,) studied this question.

synapsesocial.com/papers/68e6c841b6db643587646e15 https://doi.org/https://doi.org/10.2147/copd.s452624

KI fragen

Bookmark

View Full Paper